Skin Treatment - Baltics | Statista Market Forecast

In the Baltics, the revenue generated in the Skin Treatment market market amounts to US$45.56m in 2024.
It is projected that the market will experience an annual growth rate of 8.29% (CAGR 2024-2029).
When compared globally, the United States leads in terms of revenue generation, reaching US$4.18bn in 2024.
In relation to the total population, per person revenues of US$7.83 are achieved in 2024.
In the Baltics, there is a growing trend towards natural and organic skin treatment products in the OTC Pharmaceuticals market.

Definition: Skin Treatment Market
The Skin Treatment market comprises over-the-counter natural and synthetic medical skin treatment products like antibacterial preparations, acne treatment agents, antifungals. Preparations for skin treatment include medicines in the form of ointments, creams, gels, pills, capsules, washing lotions, peelings, pastes, solutions, fluids, suppositories and sprays for external and internal application. Not included are prescription medicines, preparations that are against the state law, are not explicit skin treatment drugs (e.g. painkillers) or primarily have cosmetic purposes. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Skin Treatment market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Agents for internal and external application
Preparations to treat skin diseases (e.g. acne treatment)

Prescription medicines
Homeopathic remedies
Painkillers
Cosmetic products
Adhesive patches

The Skin Treatment market in Baltics is experiencing steady growth due to changing customer preferences and increasing demand for skincare products. Customer preferences in the Baltics have shifted towards a greater focus on personal grooming and self-care. As people become more aware of the importance of skincare, they are willing to invest in high-quality skin treatment products. Additionally, there is a growing trend of consumers seeking natural and organic skincare products, as they are perceived to be safer and more environmentally friendly. This has led to an increase in the demand for natural and organic skin treatment products in the region.The market is also witnessing a rise in the popularity of anti-aging products. As the population in the Baltics ages, there is a greater demand for skincare products that can help reduce the signs of aging. This has led to the development of innovative anti-aging treatments and products in the market.Local special circumstances in the Baltics have also contributed to the growth of the Skin Treatment market. The region has a relatively high disposable income, which allows consumers to spend more on skincare products. Additionally, the beauty and wellness industry in the Baltics is growing rapidly, with an increasing number of beauty salons and spas offering skin treatment services. This has created a favorable environment for the growth of the market.Underlying macroeconomic factors have also played a role in the development of the Skin Treatment market in the Baltics. The region has experienced steady economic growth in recent years, which has led to an increase in consumer spending power. This has allowed consumers to allocate a larger portion of their budget towards skincare and beauty products. Furthermore, the Baltics have a well-developed retail sector, with a wide range of distribution channels available for skincare products. This has facilitated the accessibility and availability of skin treatment products to consumers.In conclusion, the Skin Treatment market in the Baltics is growing due to changing customer preferences, increasing demand for skincare products, local special circumstances, and underlying macroeconomic factors. As consumers become more conscious of their skincare routine and seek high-quality products, the market is expected to continue its upward trajectory in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.